Vitamin D and Brain Health: Reducing Dementia and Alzheimer’s Risk

Research published April 1, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology, suggests that vitamin D levels during midlife may influence long-term brain health. The study found that adults with higher levels of vitamin D in their 30s and 40s exhibited lower levels of tau protein in the brain years later.

Tau is a protein that is closely linked to the development of dementia. The findings indicate a relationship between midlife nutrient levels and the presence of biomarkers associated with Alzheimer’s disease, although researchers emphasized that the results do not prove that vitamin D directly reduces tau levels or lowers the risk of dementia.

Long-Term Study on Brain Biomarkers

The study tracked 793 adults who were free of dementia at the start of the research. At the beginning of the study, participants had an average age of 39 years, and researchers measured their blood vitamin D levels.

Approximately 16 years after the initial measurements, the participants underwent brain scans. These scans were used to evaluate levels of amyloid beta proteins and tau proteins, both of which are considered key biomarkers of Alzheimer’s disease.

The data revealed that those who maintained higher vitamin D levels during their midlife years had fewer signs of tau deposits in the brain over a decade and a half later.

These results suggests that higher vitamin D levels in midlife may offer protection against developing these tau deposits in the brain and that low vitamin D levels could potentially be a risk factor that could be modified and treated to reduce the risk of dementia

Martin David Mulligan, MB BCh BAO, University of Galway in Ireland

Scientific Context and Limitations

While the midlife study suggests a protective link, the broader scientific understanding of vitamin D and dementia remains complex. A dose-response meta-analysis of observational studies published September 10, 2025, in Front Neurol. Noted that the relationship between serum vitamin D levels and dementia risk remains unclear.

Earlier research has also highlighted various associations between vitamin D and neurological health. A study published September 2, 2014, in Neurology linked vitamin D deficiency to brain atrophy as well as ischemic stroke risk and vascular dysfunction. However, that study also noted that reverse causation is also possible, meaning that the disease process itself could potentially lead to lower vitamin D levels.

Other reporting has indicated that vitamin D supplements may be linked to a 40% reduction in dementia risk, according to a study published in the journal Alzheimer’s and Dementia: Diagnosis. Despite these various findings, medical researchers continue to caution that observational data shows a relationship rather than direct causation.

The Role of Tau and Amyloid Beta

The focus on tau and amyloid beta proteins is central to current dementia research. These proteins are markers used to identify the biological changes in the brain that typically precede the clinical symptoms of Alzheimer’s disease.

By identifying these markers in midlife or early late-life, researchers aim to find modifiable risk factors that can be treated decades before cognitive decline begins. The April 1, 2026, study suggests that vitamin D levels in the 30s and 40s could be one such factor.

Martin David Mulligan noted that while these results are promising, these results need to be further tested with additional studies to confirm whether modifying vitamin D levels can effectively reduce the risk of developing dementia.